Drugs / A. Paniculata
last change Feb 2022 re-read 3 minutes ago

A. Paniculata

Developed for
respiratory tract infectious disorder
Investigated by
Vedic Lifesciences Pvt. Ltd.

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04955327 Mar 2021 → Feb 2022 respiratory tract infectious disorder Vedic Lifesciences Pvt. Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as A. Paniculata ClinicalTrials.gov intervention name — accepted as the source's own label NCT04955327 ↗